STAT+: As controversial decisions mount, FDA shuns public advisory meetings
Stat News • 3/9/2026
Summary
No summary yet.
Advertisement
Lindy Score Breakdown (V4.2)
10h
Age
1
Sources
from cluster
10
Hours Since Seen
Final Score11/100
CategoryAntiLindy
StatusActive
Recency Multiplier87% (0.5^10/48)
Hero EligibleYes
Story Timeline
- 2026-03-09STAT+: As controversial decisions mount, FDA shuns public advisory meetings (current)
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 2 sources
Breaking Similar stories
Federal autism advisory board cancels first public meeting since overhaul
Stat News • 2 days ago
STAT+: A setback for Roche’s breast cancer drug
Stat News • Today
STAT+: Pharmalot: We’re reading about a lack of FDA adcomms, FDA loosening biosimilar rules, and more
Stat News • Today
STAT+: 5 lessons from Vinay Prasad’s turbulent tenure at the FDA
Stat News • 1 day ago
STAT+: Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial
Stat News • Today
STAT+: Health tech company says it will dive into Medicare’s new chronic care experiment
Stat News • Today
STAT+: Blue Cross Blue Shield says data back up claim that AI is driving up medical bills
Stat News • Today
STAT+: The ER staffing conflict, and no facility fee for a marmot
Stat News • Today
STAT+: Talkspace to be acquired for $835 million by mental health services giant
Stat News • Today
STAT+: After UnitedHealth moved in, Oregon sought to rein in corporate health care. Now, it’s facing an early test
Stat News • Today
Anti-Lindy Similar stories
STAT+: Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel says
Stat News • 4 weeks ago
STAT+: Hims & Hers will stop selling compounded version of Novo’s obesity pill
Stat News • 1+ months
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about TrumpRx, Hims & Hers selling compounded Wegovy pill, and more
Stat News • 1+ months
STAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patent
Stat News • 4 weeks ago
STAT+: Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill
Stat News • 1+ months
STAT+: Hims is in the crosshairs. Is a crackdown coming for compounding?
Stat News • 3 weeks ago
HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy - statnews.com
Stat News • 1+ months